Join CEO Sean Dollinger live on Cheddar TV to discuss Namaste Technologies while he makes an IMPORTANT INDUSTRY ANNOUNCEMENT. Today’s topics of discussion will also include:
American Creek Resources Ltd (TSX-V: AMK) (the “Corporationâ€) is pleased to report on an additional 17 holes from JV partner Tudor Gold’s (“Tudorâ€) 2017 drill program on the Copper Belle zone at the Treaty Creek Project located in the Golden Triangle of northwestern British Columbia.
The summary of results provided in the table below, include the most promising gold intersections reported to date. Hole CB-17-26, returned 149.1m grading 1.78 g/t gold (from 97.8 to 246.9m), including a 59.2m interval of 2.84 g/t gold (from 97.8 to 157m depth). So far, 15 of the 16 holes drilled in the Copper Belle zone contain prominent mineralization, which continues to expand the size of this potential deposit and increases the area of the resource estimate for this zone.
Walter Storm, President and CEO of Tudor Gold, stated: “The outstanding interval of gold mineralization in Hole CB-17-26–149m of 1.78 g/t gold–contains the highest average gold grade yet recorded for porphyry style mineralization on the Treaty Creek property. It also ranks among the top tier, in terms of gold grades, of the hundreds of holes drilled during the past fifteen years into multiple porphyry targets on the adjoining KSM and Brucejack-Snowfield properties of Seabridge Gold and Pretium Resources, part of the same, large hydrothermal “Sulphurets†system. The fact that we have achieved these kinds of grades in only our second year after acquiring Treaty Creek speaks both to the potential of the property and also the expertise of our geological staff. This hole will serve to further guide our exploration at Copper Belle in 2018, as well as the more than 3km of ground yet to be explored between the Copper Belle and the Iron Cap Zone of Seabridge Gold to the south, an area defined by extensive magnetotelluric anomalies.â€
Darren Blaney, President and CEO of American Creek stated: “Hole CB-17-26 is a game changer for the Treaty Creek Project. At this very preliminary stage of exploration, we have already located a significant zone of higher grade gold within the Copper Belle system. Further, the MT Survey suggests that this deposit is open in all directions, including towards Seabridge’s Iron Cap discovery located several kilometers to the south. What a terrific foundation for the upcoming 2018 drill program to expand upon.â€
The Copper Belle 2017 resource delineation drill program comprised 27 holes to depths below 700m (an estimated 13,722m) and step-outs of 50m where topography permitted. Results from additional drill holes of the 2017 drill program at Copper Belle are still pending. Drill holes were targeted oblique to the northwesterly plunge of the main mineralized zone. A block of delineated mineralization will form the basis for a preliminary resource estimate. All drill holes were down hole surveyed at 25m stations using a Reflex Multi-shot device.
Tudor’s 2016 Magnetotelluric Geophysical Survey program (MT Survey) was effectively utilized as a guide for the drill program. The MT Survey suggests that the mineralization continues to the southwest, toward the Iron Cap deposit of Seabridge Gold Inc. The MT Survey also suggests that the mineralized zone continues in all directions. Tudor’s 2017 drill program was located five kilometers north of the Iron Cap deposit and the Company intends to step out to the south in its 2018 program to see if it can determine a relationship between the two areas.
A drill map of the Copper Belle can be found here: https://orders.newsfilecorp.com/files/4494/32005_tudor1enhanced.jpg
The Qualified Person for the Treaty Creek results in this new release is James McCrea, P.Geo. for the purposes of National Instrument 43-101. He has read and approved the scientific and technical information that forms the basis for the disclosure contained in this news release.
Background on the Treaty Creek Project
The Treaty Creek Project is situated immediately north of Seabridge Gold’s KSM property and near Pretium’s Valley of the Kings Mine, both of which are located in BC’s Golden Triangle along the Sulphurets and Brucejack fault systems that continue northward into the Treaty Creek property.
Tudor conducted a major drill program (approximately 20,000 metres) on the Treaty Creek property this past summer. The objective of the drill program was to define a gold resource on the Copper Belle zone and to determine the future potential of the high grade gold/silver/zinc GR2 zone located in a separate area adjacent to the Copper Belle.
Seabridge Gold’s proposed development plan for their KSM Project includes an access tunnel system through the Treaty Creek property as a key component. The Copper Belle and GR2 deposits located on the Treaty Creek property are both situated in the area in which Seabridge is proposing to construct tunnels connecting their KSM gold deposits with critical infrastructure such as the mill and tailings facilities.
The Treaty Creek Project is a joint venture between Tudor, Teuton Resources Corp., and American Creek. Tudor is the operator and holds a 60% interest with both American Creek and Teuton each holding respective 20% carried interests in the property (American Creek and Teuton are not required to contribute to their proportionate costs until a production notice is given).
A summary of the Treaty Creek Project can be viewed here:
http://www.americancreek.com/images/pdf/Treaty_Creek_Joint_Venture_Project.pdf
About American Creek
American Creek holds a strong portfolio of gold and silver properties in British Columbia. The portfolio includes three gold/silver properties in the heart of the Golden Triangle; the Treaty Creek and Electrum joint ventures with Walter Storm/Tudor, as well as the recently acquired 100% owned past producing Dunwell Mine. Other properties held throughout BC include the Gold Hill, Austruck-Bonanza, Ample Goldmax, Silver Side, and Glitter King.
For further information please contact Kelvin Burton at: Phone: 403 752-4040 or Email: [email protected]. Information relating to the Corporation is available on its website at www.americancreek.com
Cautionary Statements regarding Forward-Looking Information
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Corporation’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. All statements other than statements of historical fact included in this release, including, without limitation, statements regarding potential mineralization and geological merits of the Treaty Creek Project and other future plans, objectives or expectations of the Corporation are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements are based on a number of material factors and assumptions. Important factors that could cause actual results to differ materially from the Corporation’s expectations include actual exploration results, changes in project parameters as plans continue to be refined, results of future resource estimates, future metal prices, availability of capital and financing on acceptable terms, general economic, market or business conditions, uninsured risks, regulatory changes, defects in title, availability of personnel, materials and equipment on a timely basis, accidents or equipment breakdowns, delays in receiving government approvals, unanticipated environmental impacts on operations and costs to remedy same, and other exploration or other risks detailed herein and from time to time in the filings made by the Corporation with securities regulators. Although the Corporation has attempted to identify important factors that could cause actual actions, events or results to differ from those described in forward-looking statements, there may be other factors that cause such actions, events or results to differ materially from those anticipated. There can be no assurance that forward-looking statements will prove to be accurate and accordingly readers are cautioned not to place undue reliance on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180116005777/en/
American Creek Resources Ltd
Kelvin Burton, 403-752-4040
[email protected]
www.americancreek.com
OTTAWA, ONTARIO–(Jan. 16, 2018) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce that it has received a No Objection Letter (NOL) from the Therapeutic Products Directorate (TPD), Health Canada to evaluate the safety, pharmacokinetics and pharmacodynamics of its cannabis oil PPP005.
According to Health Canada data1, the annual Canadian cannabis oil production for medical purposes was 22,766 kg between October 1st 2016 and September 30th 2017, and is growing continuously. In the third quarter of 2017, it grew 24% from Q2 (Apr-Jun) to Q3 (Jul-Sep)1. According to an Eight Capital analysis2, the cannabis oil market is expected to reach 1.5B$ in 2024.
The launch of this trial is the first step in Tetra’s plans to commercialize natural health products with its partners. The corporation will develop cannabis-based supplements for commercialization under the Natural Health Product regulations in Canada and in other countries where regulatory authorities have a recognized pathway for approval and commercialization of such products. The trial will eventually include formulations that will be registered as drugs under Health Canada’s TPD regulatory pathway. “Tetra Bio-Pharma Inc. seeks to become an important player in the retail market post legalization and this clinical trial is part of the sales and marketing strategy required to effectively penetrate the lucrative pharmacy and health stores retail markets,” states Bernard Fortier, CEO of Tetra.
Tetra’s vision is to develop an evidence-based approach, thereby allowing pharmacists to dispense these medicines to patients in need. Despite the growing popularity of cannabis oils, physicians and pharmacists across Canada are still hesitant to support the use of these products because of the lack of data supporting its medical use. Dr. Guy Chamberland, Chief Science Officer, commented: “This trial is part of Tetra’s corporate strategy to develop the science required to commercialize safe and efficacious cannabis oil products post-legalization and to create innovative oral drug formulations for the development of medicines in the management of pain, anxiety and the treatment of cancer.”
In that respect, Tetra’s scientific team is supporting the strategy by initiating a phase 1 clinical trial to characterize the safe use of these cannabis oil medicines in humans. Tetra has worked with Altasciences Clinical Research for the preparation of the Clinical Trial Application (CTA) for the conduct of a double-blind phase 1 study to assess safety, tolerability and pharmacokinetics of single and multiple daily doses of cannabis (Delta-9-tetrahydrocannabinol/Cannabidiol) oil capsules administered to healthy human volunteers. Health Canada issued a No Objection Letter for the conduct of the phase I clinical trial on January 12nd, 2018. Altasciences Clinical Research will be initiating the clinical trial activities in the coming weeks. The cannabis oil is manufactured by Tetra’s partner, Aphria Inc.
1: Health Canada Market Data, [https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-use-marijuana/licensed-producers/market-data.html] 2: Cannabis Sector, Eight Capital Estimates, July 2017About Tetra Bio-Pharma:
Tetra Bio-Pharma (TSX VENTURE:TBP)(OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and clinical development. Tetra is focusing on three core business pillars: clinical research, pharmaceutical promotion and retail commercialization of cannabinoid-based products.
More information at: www.tetrabiopharma.com
Source: Tetra Bio-Pharma
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a license for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research strategies, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Tetra Bio-Pharma Inc.
Dr. Anne-Sophie Courtois, DVM
Vice President, Marketing & Communications
(514) 360-8040 Ext. 210
[email protected]
MONTREAL, QUEBEC–(Jan. 15, 2018) – HPQ Silicon Resources Inc. (“HPQ”) (TSX VENTURE:HPQ)(FRANKFURT:UGE)(OTC PINK:URAGF) is pleased to inform shareholders that PyroGenesis Canada Inc (PyroGenesis) has submitted a first progress report on results from the Gen 2 PUREVAP™ Quartz Reduction Reactor (“QRR”) test work. The Gen 2 PUREVAP™ reactor is operating as designed, and yielding results that are in line with expectations. This is extremely promising for the PUREVAP™ ongoing development as process improvements and design modifications continue to be implemented.
GEN 2 PUREVAP(TM) in operation: Inside view of Reactor (Top)
GEN 2 PUREVAP(TM) in operation: Inside view of the Reactor, (Top-hole opened)
GEN 2 RESULTS START DEMONSTRATING COMMERCIAL SCALABILITY OF PUREVAP™ QRR
Key milestones to date:
Very promising output results have also been attained:
Bernard J. Tourillon, Chairman and CEO of HPQ Silicon stated, “Our methodical approach is producing exciting results as we successfully transition from a static lab scale under vacuum to a semi-continuous operating mode under vacuum, with enormous improvements in production. The market so far has not yet comprehended the scope of what has been accomplished, in the lab, and in our breakthrough agreement with Apollon Solar announced in December. Our objective in 2018 is to continue to build on our technical successes and commence the Pilot Plant phase with our ‘Solar Silicon Team’ of PyroGenesis and Apollon Solar, and to build market awareness. The addition of Apollon Solar to our technical team will allow further refinements to the silicon purification and testing of the numerous process improvements now planned for the Pilot Plant. We have started de-risking our project and our ongoing tests are providing valuable information as we continue to implement the adjustments needed to produce the Solar Grade Silicon Metal that will allow the manufacturing of multi and monocrystalline solar cells for high performance photovoltaic conversion.”
“We are pleased to join HPQ in announcing this significant milestone with respect to the scaling up of the PUREVAP™ process,” said P. Peter Pascali, President and CEO of PyroGenesis. “PyroGenesis has a track record of successfully taking new concepts from lab to commercialization. This is clearly demonstrated by our PAWDS waste destruction technology, which has been adopted by the US Navy, and more recently our proprietary Drosrite system, which has become a commercial phenomenon in its own right. We believe that simultaneously converting Quartz into High Purity Silicon Metal using a plasma arc within a vacuum furnace in a semi-continuous feeding mode is the beginning of another such success.”
KEY MILESTONES MOVING FORWARD
Milestones of the GEN 2 PUREVAP™ program in 2018 are:
Pierre Carabin, Eng., M. Eng., has reviewed and approved the technical content of this press release.
This Press Release Is Available On The Company’s CEO Verified Discussion Forum, A Moderated Social Media Platform That Enables Civilized Discussion and Q&A Between Management and Shareholders. La version française du communiqué de presse est disponible sur http://www.hpqsilicon.com.
About HPQ Silicon
HPQ Silicon Resources Inc. is a TSX-V listed resource company planning to become a vertically integrated and diversified High Purity, Solar Grade Silicon Metal (SoG Si) producer and a manufacturer of multi and monocrystalline solar cells of the P and N types, required for production of high performance photovoltaic conversion.
HPQ goal is to develop, in collaboration with industry leaders that are experts in their fields of interest, the innovative metallurgical PUREVAP™ “Quartz Reduction Reactors (QRR)” process (patent pending), which will permit production of the highest efficiency SoG Si. The pilot plant equipment that will validate the commercial potential of the process is on schedule for 2018.
Disclaimers:
This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the securities regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the images accompanying this press release, please visit the following links:
http://media3.marketwire.com/docs/HPQ_Inside_Reactor(Top)_800.jpg
http://media3.marketwire.com/docs/HPQ_Inside_Reactor(Top-hole-opened)_800.jpg
http://media3.marketwire.com/docs/HPQ_Isolated_Si_comparison_samples_800.jpg
Shares outstanding: 191,979,173
HPQ Silicon Resources Inc.
Bernard J. Tourillon
Chairman and CEO
(514) 907-1011
HPQ Silicon Resources Inc.
Patrick Levasseur
President and COO
(514) 262-9239
www.HPQSilicon.com
Montreal, January 14, 2018 – St-Georges Eco-Mining Corp. (CSE: SX) (OTC: SXOOF) (FSE: 85G1) announces that its wholly owned subsidiary, ZeU Crypto Networks Inc. (“ZeUâ€), a private blockchain technology company, has entered into a non-binding letter of intent (“LOIâ€) to acquire all of the Blockchain and Smart Contract Technologies assets (the “Transactionâ€) of Qingdao Tiande Technologies Inc. (“Tiandeâ€), a Chinese private company.
Pursuant to the terms of the LOI, the proposed consideration for the Transaction is an aggregate amount of CND$150 million payable through the issuance of 150,000,000 common shares (“Sharesâ€) and 75,000,000 Shares purchase warrants (“Warrantsâ€) in the capital of ZeU. Each Warrant will entitle the holder to acquire one (1) Share at a price of CND$1.00 for a period of three (3) years following the date ZeU completes a transaction pursuant to which its common shares will either be listed on a recognized stock exchange in North America, or will be exchanged for common shares of a reporting issuer listed on a recognized stock exchange in North America.
On January 4, 2018 St-Georges (the “Companyâ€) announced it was granted an exclusive global license to Tiande’s Blockchain and Smart Contract technology for mineral commodity production, trading and tracking. The Company assigned the License to ZeU in consideration of 20,000,000 common shares of ZeU. Whereas St-Georges owned 100% of ZeU with a license specific to the mineral commodity space, upon successful completion of the transaction, St-Georges will share ownership in ZeU, with global application reach.
“We are thrilled to enter into this agreement with Tiande and their world class scientific team. Dr. Tsai has laid out a plan to deploy what many industry experts believe to be a world class Blockchain ecosystem that stands at the threshold of a new, far-reaching technological revolution. The assets being acquired today, from the patents to the commercial and sovereign relationships and the significant human capital, are second to none in the domain. Our Ecosystem is ready to be deployed in this quarter, starting with the SandBox initiative and quickly followed by the BigData suite of solutions. Finally, the biggest and most significant mass application project, The “Internet of Blockchains†(IoB), will be released before the end of 2018. Response to IoB in every meeting with industry specialists has been significant and, in some cases, has triggered discussions into the realm of what was once unimaginable†said Frank Dumas, CEO and President of St-Georges and ZeU.
The Transaction is anticipated to close on or before February 28, 2018 with a definitive purchase agreement being entered into on or before February 5, 2018. The Transaction is subject to the approval of the Canadian Securities Exchange and certain conditions pursuant to the terms of the LOI, including the completion of a CND$20 million financing on term acceptable to ZeU and satisfactory due diligence.
ON BEHALF OF THE BOARD OF DIRECTORS
“Frank Dumasâ€
Â
FRANK DUMAS, PRESIDENT & CEO
About St-Georges
St-Georges is developing new technologies to solve the some of the most common environmental problems in the mining industry.
The Company controls directly or indirectly, through rights of first refusal, all of the active mineral tenures in Iceland. It also explores for nickel on the Julie Nickel Project & for industrial minerals on Quebec’s North Shore and for lithium and rare metals in Northern Quebec and in the Abitibi region. Headquartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1.
For Press Release Inquiries: 514.295.9878 or [email protected]
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
Today’s press release from Namaste is one of the most important in recent months – but you wouldn’t know it from the press release headline announcing a “supply agreementâ€.
This is no ordinary supply agreement … this is a GLOBAL supply agreement for CBD infused beverages, with a company whose management can be summarized as follows:
“Phivida’s management team has a strong background from the beverage industry to branding, including former senior executives from Redbull, Proctor and Gamble and McKesson’sâ€
It gets better … because this is what they said about our Namaste:
“John – David Belfontaine, President and CEO of Phivida reports: “As Phivida continues to expand is CBD product offerings into a $1 Trillion global health and wellness markets, it is critical that we secure the strongest distribution partners. Ecommerce and digital marketing is a core horizontal within our greater strategic business plan, and Namaste is an ideal partner to expand our online presence into emerging markets around the world. We look forward to launching our global digital marketing and distribution platform with Namaste’s support as a key strategic partner.â€
When a management team formerly from Redbull, P&G and McKesson’s think this highly of your company, you can only come to one conclusion..
Namazon
TORONTO, Jan. 11, 2018 — ThreeD Capital Inc. (the “Companyâ€) (CSE:IDK), a Canadian-based venture capital firm focused on investments in promising, early stage companies and ICOs with disruptive capabilities, is pleased to announce the following news from Goldspot Discoveries Inc. (“Goldspotâ€), a developer of Artificial Intelligence capable of significantly improving mineral exploration targeting. ThreeD owns approximately 18% of Goldspot’s common shares.
FINANCING FROM A PROLIFIC MINING FINANCIER AND HOCHSCHILD MINING
Goldspot recently completed a $1.3 million equity financing from a prolific mining financier, as well as Hochschild Mining plc (“Hochschildâ€). Hochschild is a leading British-based silver and gold mining company operating in North, Central and South America. In 2016, Hochschild produced 17.3 million ounces of silver and 246 thousand ounces of gold. Hochschild revenues in 2016 were US$688 million and currently trades on the London Stock Exchange with a market capitalization of US$1.7 billion.
“We are pleased that such key influencers in the mining sector have such confidence in our vision. More importantly, it is testament to the merits of our technology that one of our first clients has a vested interest in our success,†states Denis Laviolette, CEO and President of Goldspot Discoveries. “We believe that big data and machine learning are poised to disrupt the entire mining sector. Our innovation is reinvigorating an archaic sector, reducing significant risk, while giving our stakeholders the most torque for their buck.â€
RAMON BARUA AND SHELDON INWENTASH ADDED TO BOARD OF DIRECTORS
Along with the completion of this financing, Goldspot announced the appointment of Ramón Barúa and Sheldon Inwentash to the Board of Directors.
Mr. Barúa is currently the CFO of Hochschild Mining plc, a leading underground precious metals producer focusing on high grade silver and gold deposits, with over 50 years’ operating experience in the Americas. Prior to his appointment, Mr. Barúa served as CEO of Fosfatos del Pacifico, a mining project in northern Peru owned by Cementos Pacasmayo, an associate company of the Hochschild Group. During 2008, Mr. Barúa was the General Manager for Hochschild Mining’s Mexican operations, having previously worked as Deputy CEO and CFO of Cementos Pacasmayo. Prior to joining Hochschild, Mr. Barúa was a Vice President of Debt Capital Markets with Deutsche Bank in New York for four years and a sales analyst with Banco Santander in Peru.
Mr. Inwentash has more than 30 years of investing experience and success, financing hundreds of private and public start-up companies. The Financial Post called him a “A World Leader in financing junior resource firms”. Through two decades leading Pinetree Capital, Mr. Inwentash created significant shareholder value through early investments and subsequent exits in companies such as Queenston Mining (acquired by Osisko Mining Corp. for $550-million), Aurelian Resources (acquired by Kinross for $1.2-billion) and Gold Eagle Mines (acquired by Goldcorp for $1.5-billion), with the firm’s market capitalization exceeding $1 Billion at its peak.
Mr. Inwentash stated, “I want to congratulate Denis and the Goldspot team for achieving yet another important milestone. Attaining this level of acceptance with two significant influencers in global mining provides third party validation of their Artificial Intelligence capabilities. I believe this new and disruptive area of Artificial Intelligence will revolutionize the approach toward mineral discovery forever.â€
About Goldspot Discoveries Inc.
Goldspot Discoveries is a technology/investment company that has developed a machine-learning algorithm capable of significantly improving mineral exploration targeting on both a regional and local scale. The Goldspot Algorithm is proven to mitigate investment risk and increase the efficiency and success rate of exploration in data-rich environments. The company plans to lever this technology to create a new and exciting investment opportunity for the market, and to give its stakeholders the greatest upside in the mining sector while reducing the risk.
Goldspot Discoveries is aiming to completely change the investment decision model by using the Goldspot Algorithm to stake acreage, acquire projects and royalties, and invest in public vehicles to ultimately create a portfolio of assets with the greatest reward to risk ratio. Already, the company has staked highly prospective targets in the Abitibi region and is currently working with companies to delineate further targets in Ontario, West Africa, Nevada, Arizona, and South America.
About ThreeD Capital Inc.
ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the Junior Resources, Artificial Intelligence and Blockchain sectors. ThreeD seeks to invest in early stage, promising companies and ICOs where it may be the lead investor and can additionally provide investees with advisory services, mentoring and access to the Company’s ecosystem.
For further information: Gerry Feldman, CPA, CA Chief Financial Officer and Corporate Secretary [email protected]
telephone: 416 606 7655
MONTREAL, Jan. 11, 2018 – MONARQUES GOLD CORPORATION (“Monarques” or the “Corporation”) (TSX.V:MQR) (OTCMKTS:MRQRF) (FRANKFURT:MR7) is pleased to report the results of its exploration drilling program at the Beaufor Mine. The 2,239-metre program was aimed at increasing the resource in two sectors of the Beaufor Mine, Zone Q and Zone 1700.
Zone Q Sector
Zone Q is the main zone of current production at the Beaufor Mine.
Two new holes were drilled in the eastern extension of Zone Q, outside the known mineralized envelope, to test the continuity of the structure and check for the presence of mineralized veins in the hangingwall and footwall of the zone. Holes 150-60a and 150-61 (see Sections 1810E and 1855E) were drilled to a depth of 534 and 558 metres, respectively. They intersected Zone Q, as well as several mineralized veins (QH Zone) located 20 to 60 metres from the hangingwall of the zone. A number of mineralized veins were also intersected 10 to 100 metres away from the Zone Q footwall (QF Zone).
These new mineralized zones are similar in nature to the typical known veins at the Beaufor Mine, which are quartz-tourmaline veins with disseminated pyrite associated with diorite dikes.
The best results returned by Zones QH and QF were as follows:
These two holes, spaced at about 45 metres apart, appear to confirm the lateral continuity of Zone QH and Zone Q, which may remain open to the east.
“These initial drill results confirm the strong exploration potential in the area to the east of Zone Q,” said Jean-Marc Lacoste, President and Chief Executive Officer of Monarques. “The intersection of several lenses with significant grades on both sides of the zone is ample reason to explore the area in more detail. Our strategy is to continue testing the mineralization in the east and at depth in order to increase the mineral resource at the Beaufor Mine.”
Zone 1700 Sector
The Zone 1700 sector lies east of the 1500 level of the Beaufor Mine, 458 metres below surface. A few historical holes intersected mineralized lenses with gold values of over 3 g/t.
Four new holes were drilled to test the extensions of those mineralized lenses. The results for holes 152-18, 160-14, 168-04 and 176-01 provided a better understanding of the structure and size of the lenses (see 1500 level plan). Zone 1700 remains open vertically but is not laterally continuous and may be confined by two structures striking N80°.
The most significant grades were intersected in holes 160-14 and 152-18 and appear to indicate the presence of two new zones:
The extensions of these mineralized lenses are still not well defined and additional drilling is needed for a better understanding of their geometry.
Quality control and qualified person
Sampling normally consists of sawing the core into two equal halves along its main axis and shipping one of the halves to the ALS Minerals laboratory in Val-d’Or for assaying. The samples are crushed, pulverized and assayed by fire assay with atomic absorption finish. Results exceeding 10.0 g/t are re-assayed using the gravity method. Certified standards and blanks are inserted into the sampling stream for quality control purposes.
The technical and scientific content of this press release has been reviewed and approved by Élise Bourgault, P.Geo., the Corporation’s qualified person under National Instrument 43‑101.
ABOUT MONARQUES GOLD CORPORATION
Monarques Gold Corp (TSX-V: MQR) is an emerging gold producer focused on pursuing growth through its large portfolio of high-quality projects in the Abitibi mining camp in Quebec, Canada. The Corporation currently owns close to 300 km² of gold properties (see map), including the Beaufor Mine, the Croinor Gold (see video), Wasamac, McKenzie Break and Swanson advanced projects, and the Camflo and Beacon mills, as well as six promising exploration projects. It also offers custom milling services out of its 1,600 tonne-per-day Camflo mill. Monarques enjoys a strong financial position and has more than 150 skilled employees who oversee its operating, development and exploration activities.
Forward-Looking Statements
The forward-looking statements in this press release involve known and unknown risks, uncertainties and other factors that may cause Monarques’ actual results, performance and achievements to be materially different from the results, performance or achievements expressed or implied therein. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
Table 1:Â Summary of drill results on the Beaufor Mine
Zone QÂ sector: True width is approximately 80% of the length of the intersection.
Zone 1700Â sector: True width is approximately 50% of the length of the intersection.
SOURCE Monarques Gold Corporation
View original content with multimedia: http://www.newswire.ca/en/releases/archive/January2018/11/c3572.html
Jean-Marc Lacoste, President and Chief Executive Officer, 1-888-994-4465, [email protected], www.monarquesgold.com; ElisabethTremblay, Senior Geologist – Communications Specialist, 1-888-994-4465, [email protected], www.monarquesgold.comCopyright CNW Group 2018
ESCONDIDO, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) — via NetworkWire – MARIJUANA COMPANY OF AMERICA INC. (“MCOA†or the “Companyâ€) (OTC:MCOA), an innovative hemp and cannabis corporation, is pleased to announce the release of hempSMART™ Full Spectrum Pet Drops formulated for cats and dogs.
Each bottle of hempSMART Full Spectrum Pet Drops is formulated with 250mg of full spectrum non-psychoactive Cannabidiol (CBD) derived from industrial hemp. The new specially formulated product contains naturally occurring CBD derived from hemp seed oil, full spectrum hemp extract, fractionated coconut oil, and a rich bacon flavor.
Donald Steinberg, MCOA’s CEO said, “Our new hempSMART product is a natural option for pet owners who care about supporting their animals’ healthy energy levels as well as optimizing their health. Our hempSMART product line will continue to expand to other popular areas of consumer interest to give our affiliates what they need to succeed.â€
In reviewing pet supplement trends for 2017, Watson, Inc.’s Mona Hollums observed that natural pet supplement sales nearly doubled between 2008 and 2014. With the increasing focus on pet health, the market for pet supplements is projected to show significant and continuing expansion. Projections show that U.S. retail sales of pet supplements and nutraceuticals treats will grow 3%-5% annually, bringing the market to $1.6 billion. Globally, the pet supplement market is also expected to grow even further. Between 2016-2020, sales are projected to increase over 5% and will continue to yield lucrative investment payouts.
About Our hempSMART Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.
About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™â€, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.
Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.
For more information, please visit the Company’s websites at:
MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA
Corporate Communications Contact:Â
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]
VANCOUVER, British Columbia, Jan. 11, 2018 — Namaste Technologies Inc. (“Namaste†or the “Companyâ€) (CSE:N), (FRANKFURT:M5BQ), (OTCMKTS:NXTTF) is pleased to announce that it has signed a Global Digital Reseller-Supply Agreement (the “Agreementâ€) with Phivida Holdings Inc. (“Phividaâ€) (CSE:VIDA), (OTCMKTS:PHVAF).
As key terms in the agreement, Namaste has been approved as the preferred global online retailer and digital affiliate marketing partner for Phivida’s product line of premium hemp-derived Cannabidiol (“CBDâ€) infused functional beverages and clinical health products. The agreement includes a global online territory, targeting the launch in Germany and Australia (the “Territoriesâ€).
Phivida CBD beverages, extracts, juices and shots are professionally formulated by health care practitioners, made with premium ingredients, tested for quality, safety and manufactured to GMP standards. This Agreement represents a strategic initiative between both companies to promote high quality CBD products through Namaste’s platform and to the Company’s existing databases of users within the Territories. CBD is a cannabinoid compound which can be derived from both cannabis and hemp plants and plays a vital role in the emerging global medical cannabis market.
With Phivida’s management team having a strong background from the beverage industry and branding, including former senior executives from Redbull, Proctor and Gamble and McKesson’s, Namaste is pleased to be able to offer Phivida’s premium CBD beverages and infusions to its patients and practitioners globally, with an initial launch in Australia and Germany.
Terms of the Agreement
Namaste’s globally diversified network of e-commerce sites and distribution centers will allow Namaste, in its partnership with Phivida, to reach users in new and emerging medical cannabinoid based medical and consumer health markets. This Agreement further represents Namaste’s commitment to deploy its strategic initiatives in an effort to bring the most innovative products to market. Namaste’s growing global database of consumers continues to provide value to the Company and its partners, as it aims to leverage its technical expertise relating to its cutting-edge SEO and machine learning technologies.
This Agreement represents a pilot project between both companies whereby Namaste will distribute Phivida’s proprietary CBD beverages and infused products within the designated territories. Both companies intend on further expanding distribution through other markets where Namaste maintains significant market share.
While the Canadian market remains a primary focus for Namaste, it has identified additional opportunities in the Australian and German markets, as both countries continue to demonstrate a keen willingness to move closer towards full legalization. This partnership will allow Namaste to transition seamlessly into both markets, as it looks to broaden the scope of the products and services it provides. This Agreement represents an important step for Namaste as it looks to expand its presence into emerging markets and believes Phivida’s CBD beverages, oils and infusions offer Namaste an incredible opportunity to expand its offering globally.
Management Commentary
Sean Dollinger, President and CEO of Namaste comments: “Namaste is extremely excited to be partnering with Phivida and its world-class management team. We’re looking forward to entering the beverage space together with Phivida as we believe there is significant demand for these products in our market. Many of our successes to this point can be largely attributed to our keen ability in identifying industry leaders and then forming strategic alliances. Our partnership with Phivida further demonstrates that ability, and we feel very optimistic to be collaborating with a management team whose pedigree speaks for itself.  We would like to thank Phivida for granting Namaste rights of its online retail products in the Territories, as we expand our presence globally.
We fully expect this partnership to evolve and fully intend on exhausting all opportunities whereby both parties are able grow and expand their respective market share. Not only does this offer Namaste the ability to expand its product line but so too does it help us in penetrating new markets as we look to create the world’s most expansive online medical cannabis marketplace.â€
John – David Belfontaine, President and CEO of Phivida reports: “As Phivida continues to expand is CBD product offerings into a $1 Trillion global health and wellness marketi, it is critical that we secure the strongest distribution partners. Ecommerce and digital marketing is a core horizontal within our greater strategic business plan, and Namaste is an ideal partner to expand our online presence into emerging markets around the world. We look forward to launching our global digital marketing and distribution platform with Namaste’s support as a key strategic partner.â€
About Namaste Technologies Inc.Â
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, US, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.
About PhividaÂ
Phivida [“fiii-vee-daaâ€] is a publicly traded company listed on the Canadian Securities Exchange under the ticker symbol “VIDAâ€. Phivida is a premiere brand of cannabidiol (“CBDâ€) infused functional foods, beverages and clinical health products, poised for global distribution. Using nanoencapsulation technology, Phivida converts lipid based cannabinoids into water soluble delivery format, enhancing bioavailability, and timed released within the body. Phivida’s nanoencapsulated CBD is infused into CBD beverages, foods and supplements containing a proprietary blend of phytonutraceuticals studied to target a range of health conditions, from chronic pain to terminal diseases. Phivida Enhanced Inc. (a wholly owned subsidiary of Phivida Holdings Inc.) is the clinical division of Phivida responsible for the formulation, manufacturing and distribution of the professional line clinical products under the brand name Vida+. These clinical grade CBD products include sublingual’s, hard capsules and other full spectrum CBD-hemp oil extract infused nutraceuticals and natural health products. The Vida+ label is a professional line of products clinical grade for higher potency and are third party laboratory tested for cannabinoid potency, terpenes, residual solvents, bacteria and pesticides. Celebrating; Health and Wellness, In Harmony™, Phivida’s mission is to lead the alternative health care sector as the benchmark quality standard in premium cannabinoid infused foods, beverages and clinical products, with a dedication to research, education and investing back into the communities that we so proudly serve.
For investor relations inquiries and updates, please contact Phivida via the information listed below.
Website www.phivida.com Toll free +1 (844) 744-6646 (ext. #2) E-mail [email protected]   Twitter https://twitter.com/Phivida Facebook                 https://www.facebook.com/phivida YouTube https://www.youtube.com/watch?v=YqvHSMbhKwQ&t=7s
Forward Looking Information
This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.
Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.
On behalf of the Board of Directors
“Sean Dollingerâ€
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]
Further information on the Company and its products can be accessed through the links below:
www.namastetechnologies.com
www.namastevaporizers.co.uk
www.everyonedoesit.co.uk
